1. Home
  2. BSL vs INGN Comparison

BSL vs INGN Comparison

Compare BSL & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackstone

BSL

Blackstone

HOLD

Current Price

$13.07

Market Cap

167.1M

Sector

Finance

ML Signal

HOLD

Logo Inogen Inc

INGN

Inogen Inc

HOLD

Current Price

$7.36

Market Cap

172.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSL
INGN
Founded
2010
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
167.1M
172.4M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
BSL
INGN
Price
$13.07
$7.36
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$11.25
AVG Volume (30 Days)
36.4K
266.8K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
9.55%
N/A
EPS Growth
N/A
43.42
EPS
N/A
N/A
Revenue
N/A
$348,668,000.00
Revenue This Year
N/A
$8.03
Revenue Next Year
N/A
$7.76
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.86
52 Week Low
$12.45
$5.34
52 Week High
$14.35
$9.13

Technical Indicators

Market Signals
Indicator
BSL
INGN
Relative Strength Index (RSI) 53.81 66.92
Support Level $12.53 $7.30
Resistance Level $13.35 $7.85
Average True Range (ATR) 0.21 0.35
MACD 0.01 0.07
Stochastic Oscillator 53.97 79.61

Price Performance

Historical Comparison
BSL
INGN

About BSL Blackstone

Blackstone Senior Floating Rate Term Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. The fund also invests in second-lien loans and high yield bonds and employs financial leverage which may increase the risk to the Fund.

About INGN Inogen Inc

Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.

Share on Social Networks: